Clinical indications of premenstrual disorders and subsequent risk of injury: a population-based cohort study in Sweden

被引:13
作者
Yang, Qian [1 ]
Sjolander, Arvid [1 ]
Li, Yuchen [1 ]
Viktorin, Alexander [1 ]
Bertone-Johnson, Elizabeth R. [2 ,3 ]
Ye, Weimin [1 ]
Fang, Fang [4 ]
Valdimarsdottir, Unnur A. [1 ,5 ,6 ]
Lu, Donghao [4 ,6 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden
[2] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Biostat & Epidemiol, Amherst, MA 01003 USA
[3] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, Amherst, MA 01003 USA
[4] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden
[5] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, IS-101 Reykjavik, Iceland
[6] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
基金
瑞典研究理事会;
关键词
Premenstrual disorders; Injury; Suicidal behavior; Accidents; Cohort study; QUALITY-OF-LIFE; DYSPHORIC DISORDER; WOMEN; SUICIDE; ABUSE; SCHIZOPHRENIA; DROSPIRENONE; EPIDEMIOLOGY; PREVALENCE; DIAGNOSIS;
D O I
10.1186/s12916-021-01989-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Premenstrual disorders, including premenstrual syndrome and premenstrual dysphoric disorder, are suggested to be correlated with suicidal behavior and accidents in cross-sectional and retrospective studies. However, prospective data are still lacking. Methods We performed a population-based cohort study including 1,472,379 Swedish women of reproductive age who were followed from 2001 to 2012. Within the cohort, we also performed a sibling analysis where we compared the rates of injury between full sisters. By linking to the Patient and the Prescribed Drug Registers, we identified 18,628 women with any clinical indications for premenstrual disorders in the cohort (population analysis) and 7674 women in the sibling analysis. Any injury, primarily suicidal behavior (completed suicide and suicide attempt) or accidents (e.g., fall and transportation accidents), was identified through the Patient and Causes of Death Registers as the primary outcome. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) of these outcomes among women with premenstrual disorders in both population and sibling analyses using multivariable Cox proportional hazards regression. Results During a maximal follow-up of 12 years (mean 9.55 years), we identified 2390 women with premenstrual disorders with any injury; 216 through suicidal behavior and 2191 through accidents. Compared to women without premenstrual disorders, women with premenstrual disorders were at increased risk of any injury (HR 1.37, 95% CI 1.31-1.42), particularly suicidal behavior (HR 2.26, 95% CI 1.97-2.59) and accidents (HR 1.32, 95% CI 1.27-1.38). Such associations somewhat attenuated yet remained significant in the sibling analysis (HRs: 1.31 for any injury, 1.86 for suicidal behavior, and 1.29 for accidents). Additional adjustment for psychiatric comorbidities minimally altered the associations with any injury and accidents in both population and sibling analyses, whereas the association with suicidal behavior was considerably attenuated to non-significance in the sibling analysis. Such risks were particularly strong within 2 years after receiving the diagnosis of premenstrual disorders and were evident among women with premenstrual disorders with and without psychiatric comorbidities. Conclusions Our findings suggest that women with a clinical indication of premenstrual disorders are at increased subsequent risk of injury, particularly accidents within the first 2 years after diagnosis.
引用
收藏
页数:12
相关论文
共 61 条
  • [51] FLUOXETINE IN THE TREATMENT OF PREMENSTRUAL DYSPHORIA
    STEINER, M
    STEINBERG, S
    STEWART, D
    CARTER, D
    BERGER, C
    REID, R
    GROVER, D
    STREINER, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) : 1529 - 1534
  • [52] Comparing measurement error correction methods for rate-of-change exposure variables in survival analysis
    Veronesi, Giovanni
    Ferrario, Marco M.
    Chambless, Lloyd E.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2013, 22 (06) : 583 - 597
  • [53] The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
    Wettermark, Bjorn
    Harnmar, Niklas
    MichaelFored, C.
    Leimanis, Andrejs
    Olausson, Petra Otterblad
    Bergman, Ulf
    Persson, Ingemar
    Sundstrom, Anders
    Westerholm, Barbro
    Rosen, Mans
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) : 726 - 735
  • [54] Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
    Wittchen, HU
    Becker, E
    Lieb, R
    Krause, P
    [J]. PSYCHOLOGICAL MEDICINE, 2002, 32 (01) : 119 - 132
  • [55] Burden of premenstrual dysphoric disorder on health-related quality of life
    Yang, Min
    Wallenstein, Gene
    Hagan, Michael
    Guo, Amy
    Chang, Joanne
    Kornstein, Susan
    [J]. JOURNAL OF WOMENS HEALTH, 2008, 17 (01) : 113 - 121
  • [56] Yang M, 2010, J REPROD MED, V55, P41
  • [57] Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder
    Yonkers, KA
    Brown, C
    Pearlstein, TB
    Foegh, M
    Sampson-Landers, C
    Rapkin, A
    [J]. OBSTETRICS AND GYNECOLOGY, 2005, 106 (03) : 492 - 501
  • [58] Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment - A randomized controlled trial
    Yonkers, KA
    Halbreich, U
    Freeman, E
    Brown, C
    Endicott, J
    Frank, E
    Parry, B
    Pearlstein, T
    Severino, S
    Stout, A
    Stone, A
    Harrison, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (12): : 983 - 988
  • [59] Premenstrual syndrome
    Yonkers, Kimberly Ann
    O'Brien, P. M. Shaughn
    Eriksson, Elias
    [J]. LANCET, 2008, 371 (9619) : 1200 - 1210
  • [60] Premenstrual disorders
    Yonkers, Kimberly Ann
    Simoni, Michael K.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : 68 - 74